ODC1 and colorectal carcinoma: Similar results were obtained with the irreversible ODC inhibitor DFMO (Supplementary Fig. 1c–d), which significantly inhibited EIF5A hypusination and tumor cell growth, demonstrating the dependence on polyamine metabolism for CRC growth.